These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18952077)

  • 21. Pancreas carcinoma antigen fused to invariant chain elicits T-cell response and tumor growth inhibition.
    Nagaraj S; Neumann J; Winzen B; Frank S; Ziske C; Sievers E; Koch N; Schmidt-Wolf IG
    Pancreas; 2008 Oct; 37(3):321-7. PubMed ID: 18815556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
    Otten LA; Leibundgut-Landmann S; Huarte J; Kos-Braun IC; Lavanchy C; Barras E; Borisch B; Steimle V; Acha-Orbea H; Reith W
    Eur J Immunol; 2006 Jun; 36(6):1548-58. PubMed ID: 16703565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrosarcoma cells expressing allogeneic MHC Class II antigens induce protective antitumor immunity.
    Leach DR; Callahan GN
    J Immunol; 1995 Jan; 154(2):738-43. PubMed ID: 7814880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
    Choi YE; Yu HN; Yoon CH; Bae YS
    Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine neuroblastoma vaccines produced by retroviral transfer of MHC class II genes.
    Hock RA; Reynolds BD; Tucker-McClung CL; Heuer JG
    Cancer Gene Ther; 1996; 3(5):314-20. PubMed ID: 8894250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New strategies of mammary cancer vaccination.
    Accolla RS; Frangione V; De Lerma Barbaro A; Mortara L
    Breast J; 2010; 16 Suppl 1():S42-4. PubMed ID: 21050309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Radosevich M; Jager M; Ono SJ
    Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA; Rimsza LM; Murphy SP
    Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors.
    Schindler M; Wildum S; Casartelli N; Doria M; Kirchhoff F
    AIDS; 2007 May; 21(9):1103-7. PubMed ID: 17502720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mice deficient in invariant-chain and MHC class II exhibit a normal mature B2 cell compartment.
    Maehr R; Kraus M; Ploegh HL
    Eur J Immunol; 2004 Aug; 34(8):2230-6. PubMed ID: 15259020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed allograft rejection by the suppression of class II transactivator.
    Kim TW; Choi YM; Seo JN; Kim JH; Suh YH; Chung DH; Jung KC; Oh KI
    Exp Mol Med; 2006 Jun; 38(3):210-6. PubMed ID: 16819279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii protein.
    Wang Y; Xu M; Che M; Von Hofe E; Abbas A; Kallinteris NL; Lu X; Liss ZJ; Forman JD; Hillman GG
    Hum Gene Ther; 2005 Feb; 16(2):187-99. PubMed ID: 15761259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential nerve injury-induced expression of MHC class II in the mouse correlates to genetic variability in the type I promoter of C2ta.
    Harnesk K; Swanberg M; Diez M; Olsson T; Piehl F; Lidman O
    J Neuroimmunol; 2009 Jul; 212(1-2):44-52. PubMed ID: 19481818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA.
    Schnappauf F; Hake SB; Camacho Carvajal MM; Bontron S; Lisowska-Grospierre B; Steimle V
    Eur J Immunol; 2003 Aug; 33(8):2337-47. PubMed ID: 12884309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
    Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
    J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of alloresponse by a human trophoblast non-coding RNA suppressing class II transactivator promoter III and major histocompatibility class II expression in murine B-lymphocytes.
    Geirsson A; Bothwell AL; Hammond GL
    J Heart Lung Transplant; 2004 Sep; 23(9):1077-81. PubMed ID: 15454174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MHC II and the endocytic pathway: regulation by invariant chain.
    Landsverk OJ; Bakke O; Gregers TF
    Scand J Immunol; 2009 Sep; 70(3):184-93. PubMed ID: 19703008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibition effect of CIITA anti-sense cDNA on the expression of MHCII molecules of Hela cells].
    Guo R; Zou P; Fan HH; Cui L; Cao YL; Zheng B; Gao L; Gao F; Lu HZ
    Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):636-9. PubMed ID: 14761611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged MHC class II expression and CIITA transcription in human keratinocytes.
    Takagi A; Nishiyama C; Kanada S; Niwa Y; Fukuyama K; Ikeda S; Okumura K; Ogawa H
    Biochem Biophys Res Commun; 2006 Aug; 347(2):388-93. PubMed ID: 16836979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.